Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
SION
Sionna Therapeutics, Inc.
NASDAQGM
Biotechnology
United States
$7.18
▲
+0.43 (+6.37%)
CLOSED
—
OPEN
$7.31
HIGH
$7.22
LOW
$6.62
PREV CLOSE
$6.75
VOLUME
916.5K
0.49x avg
BID / ASK
35.98 / 64.74
spr 28.76
MARKET CAP
$324.2M
DAY RANGE
$6.62
$7.22
P/E (TTM)
—
Fwd -2.8
EPS (TTM)
-2.15
DIV YIELD
—
52W HIGH
$54.97
-86.9%
52W LOW
$4.01
+79.1%
BETA
—
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$7.13
-0.05
(-0.70%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
SION
$7.18
▲
+6.37%
Chart
Valuation
Financials
Peers
News
SION · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-OFF
251 BARS · -71.9% YOY
1-year price chart. Started at 24.00, currently 6.75, down 71.9 percent. Range 4.50 to 51.04 over 251 data points.
2025-09-05
$24.00 → $6.75 (-71.9%)
2026-09-03
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$21.52
WACC Used
+7.0%
Terminal g
+3.5%
Verdict: strong-buy
· peers $21.52 (+199.7%)
Peers:
AS PE30
APTV PE22
ATI PE62
BMRN PE180
BTSG PE54
DMRA
DKS PE15
DPC
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
—
2 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
—
-$75.3M
-$66.3M
-$66.7M
$326.0M
2024-12
—
-$61.7M
-$52.8M
-$52.8M
$185.8M
PEERS
Sector & Industry Peers
CALM
10 PEERS · FINNHUB
AS
APTV
ATI
BMRN
BTSG
DMRA
DKS
DPC
FDXF
RACE
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Motley Fool · 2026-08-20
Sionna Therapeutics (SION) Resets After Trial Miss, Is The Discount Now Too Deep?
Simply Wall St. · 2026-08-13
Sionna Therapeutics (SION) Is Down 86.8% After Halting SION-719 And Refocusing Its CF Pipeline – Has The Bull Case Changed?
Simply Wall St. · 2026-08-13
Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says
MT Newswires · 2026-08-12
Sionna Therapeutics (SION) Stock Still Looks Cheap After The 90% Fall
Simply Wall St. · 2026-08-12
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses
Insider Monkey · 2026-08-12
Sionna Therapeutics stock falls 92% after SION-719 trial failure
Quartz · 2026-08-11
BTIG Downgrades Sionna Therapeutics to Neutral From Buy
MT Newswires · 2026-08-11